{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-221544","form_type":"8-K","ticker":"CPRX","cik":"0001369568","company_name":"CATALYST PHARMACEUTICALS, INC.","filed_at":"2023-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.719497+00:00","generated_at":"2026-06-11T03:21:53.248521+00:00","sec_items":["5.02","5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Catalyst Pharma elects seven directors at annual meeting; Philip Coelho retires from board","bullets":["Patrick J. McEnany, Richard J. Daly, Donald A. Denkhaus, Molly Harper, Charles B. O’Keeffe, Tamar Thompson, and David S. Tierney elected to board for 2024 term.","Philip H. Coelho, board member since 2002, did not stand for re-election; retirement not due to any disagreement.","Shareholders approved amendment to 2018 Stock Incentive Plan with 73.2M for, 2.7M against.","Advisory vote on named executive officer compensation passed with 72.6M for, 2.9M against.","Ratification of Grant Thornton as auditor for FY2023 approved with 87.6M for, 0.3M against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-221544","json":"https://secwatch.observer/filing/0001193125-23-221544.json","markdown":"https://secwatch.observer/filing/0001193125-23-221544.md","text":"https://secwatch.observer/filing/0001193125-23-221544.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369568/000119312523221544/0001193125-23-221544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369568/000119312523221544/d540429d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T03:21:53.248521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ff53c7a130","claim":"Philip H. Coelho retired as Director at CATALYST PHARMACEUTICALS, INC..","evidence_excerpt":"Philip H. Coelho, an independent member of the Board, did not stand for re-election at the Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1369568/000119312523221544/0001193125-23-221544-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}